Home / Drug shortages / Sumatriptan Nasal Spray

Sumatriptan Nasal Spray — FDA Drug Shortage

To Be Discontinued — Prasco Laboratories

The FDA lists a drug shortage record for Sumatriptan Nasal Spray (nasal spray) from Prasco Laboratories with status To Be Discontinued. The shortage was first posted on 09/08/2025.

Shortage Details

Status
To Be Discontinued
Company
Prasco Laboratories
Package NDC
66993-082-69
Dosage Form
Nasal Spray
Presentation
Imitrex, Nasal Spray, 20 mg/100 uL (NDC 66993-082-69)
Initial Posting
09/08/2025
Revised Date

FDA data resources